ACHV vs TERN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
TERN Captures Institutional Edge (3โ1 Pillars ยท 4โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Terns Pharmaceuticals, Inc. Common Stock (TERN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while ACHV counters with relative strength in Valuation. Fundamentally, ACHV trades at 35.3x Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus TERN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ACHV sits in BREAKOUT (23rd %ile IV; Dealer Gamma Walls on Pro) against TERN sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ACHV | TERN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $692.8M | $6.1B | Larger Scale | TERN |
| Trailing P/E Ratio Valuation | 35.3x | N/M | Lower Multiple | ACHV |
| Forward P/E Ratio Valuation | 35.3x | N/M | Lower Multiple | ACHV |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -845.0% | -14.2% | Higher ROE | TERN |
| 52-Week Range Position Momentum | 69% ($3โ$9) | 100% ($3โ$53) | Stronger Trend | TERN |
| Beta / 30D Volatility Risk Regime | 1.73ฮฒ ยท 62% Vol | 0.07ฮฒ ยท 2% Vol | Lower Realized Risk | TERN |
| Unified Institutional Score Composite Signal | 56.6 / 100 (HOLD) | 51.9 / 100 (HOLD) | Higher Composite | ACHV |